Cargando…

Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1–2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

BACKGROUND: Omitting axillary lymph node dissection (ALND) is recommended for early-stage breast cancer patients with 1–2 sentinel lymph nodes (SLNs) macro-metastases and breast-conserving therapy. However, it is not safe for part of patients, so it is significant to find risk factors and develop a...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, Xiangyu, GAO, Yinqi, YANG, Xue, KONG, Xiangyi, WANG, Zixing, FANG, Yi, WANG, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548499/ https://www.ncbi.nlm.nih.gov/pubmed/33083292 http://dx.doi.org/10.18502/ijph.v49i7.3579

Ejemplares similares

Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer
por: Gherghe, M, et al.
Publicado: (2015)

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation
por: Zhong, Ying, et al.
Publicado: (2020)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
por: Bhattacharya, I.S., et al.
Publicado: (2018)

Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound (CEUS) in breast cancer patients
por: Wang, Ying, et al.
Publicado: (2017)

Breast cancer in older woman: can axillary dissection be omitted?
por: Barberini, Francesco, et al.
Publicado: (2009)

Transcutol(®) P Containing SLNs for Improving 8-Methoxypsoralen Skin Delivery
por: Pitzanti, Giulia, et al.
Publicado: (2020)

Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix
por: Gao, Peng, et al.
Publicado: (2020)

Comparison of [(99m)Tc]Tilmanocept and Filtered [(99m)Tc]Sulfur Colloid for Identification of SLNs in Breast Cancer Patients
por: Baker, Jennifer L., et al.
Publicado: (2014)

Omitted Acknowledgment
Publicado: (2020)

Reference Omitted
Publicado: (2023)

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
por: Satapathy, Mantosh Kumar, et al.
Publicado: (2021)

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival
por: Vos, Elvira L., et al.
Publicado: (2017)

Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?
por: Taylor, Caitlin, et al.
Publicado: (2022)

Omitting radiotherapy in elderly breast cancer patients: Valid strategy or illusory hope?
por: Kouhen, Fadila
Publicado: (2023)

Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
por: Mura, Paola, et al.
Publicado: (2021)

Non-sentinel lymph node metastases risk factors in patients with breast cancer with one or two sentinel lymph node macro-metastases
por: Xu, Liu-yan, et al.
Publicado: (2023)

Effect of Palm or Coconut Solid Lipid Nanoparticles (SLNs) on Growth of Lactobacillus plantarum in Milk
por: Jo, Yeon-Ji, et al.
Publicado: (2015)

Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
por: Cheng, Ran, et al.
Publicado: (2020)

Comparison of Oncoplastic Breast-Conserving Therapy and Standard Breast-Conserving Therapy in Early-Stage Breast Cancer Patients
por: Zhou, Yuan, et al.
Publicado: (2020)

Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database
por: Yang, Zejian, et al.
Publicado: (2021)

Should Intercepting Traps Be Omitted?
Publicado: (1912)

Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy
por: Yüksel, Cemil, et al.
Publicado: (2022)

The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients
por: Hu, Weixu, et al.
Publicado: (2013)

Preparation and Characterization of Tacrolimus-Loaded SLNs in situ Gel for Ocular Drug Delivery for the Treatment of Immune Conjunctivitis
por: Sun, Kexin, et al.
Publicado: (2021)

Transferrin-Modified Mangiferin-Loaded SLNs: Preparation, Characterization, and Application in A549 Lung Cancer Cell
por: Zhou, Qi, et al.
Publicado: (2022)

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
por: Mehrdadi, Soheil
Publicado: (2023)

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020)

A Systematic Study on Zinc-Related Metabolism in Breast Cancer
por: Qu, Zheng, et al.
Publicado: (2023)

Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis
por: Kim, Yi-Jun, et al.
Publicado: (2019)

Expression signatures and roles of microRNAs in inflammatory breast cancer
por: Qi, Yihang, et al.
Publicado: (2019)

The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
por: Dong, Hao, et al.
Publicado: (2023)

Omitting the systematic prostate biopsy: ready for prime time?
por: Leong, Joon Yau, et al.
Publicado: (2023)

Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study
por: Ai, Bolun, et al.
Publicado: (2020)

DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment
por: Kumari, Mamta, et al.
Publicado: (2021)

The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
por: Zhu, Mengliu, et al.
Publicado: (2022)

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020)

Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
por: Sun, Zhi-Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_795j8g8tqmlmqqoad6c45p1r97